
Experts push to uphold credible climate science findings as Trump administration spreads doubt
The report, published late last month, claimed concerns about planet-warming fossil fuels are overblown, sparking widespread concern from scientists who said it was full of climate misinformation. It came as an attempt to support a proposal from the the Environmental Protection Agency (EPA) to undo the 'endangerment finding', which forms the legal basis of virtually all US climate regulations.
'A public comment from experts can be useful because it injects expert analysis into a decision-making process that might otherwise be dominated by political, economic, or ideological considerations,' said Andrew Dessler, a climate researcher at Texas A&M University who is organizing the response to the report. 'Experts can identify technical errors, highlight overlooked data, and clarify uncertainties in ways that improve the accuracy and robustness of the final policy or report.'
The response comes as part of a broader wave of experts' attempts to uphold established climate science as the Trump administration promotes contrarian and unproven viewpoints.
The National Academies of Sciences, Engineering, and Medicine (NASEM), the country's top group of scientific advisers, has launched a 'fast-track' review of the latest evidence on how greenhouse gases threaten human health and wellbeing – a move announced following the proposed endangerment finding rollback.
NASEM, which advises the EPA and other federal agencies, plans to release their findings in September, in time to inform the EPA's decision on the endangerment finding. The initiative will be self-funded by the organization – a highly unusual practice from the congressionally chartered group, which usually responds to federal bodies' calls for advice.
'It is critical that federal policymaking is informed by the best available scientific evidence,' said Marcia McNutt, president of the National Academy of Sciences, in a statement.
Trump administration efforts to block access to data have also inspired pushback. This month, the president ousted the head of the Bureau of Labor Statistics after baselessly saying the data it publishes is 'RIGGED'.
In earlier weeks, federal officials have also deleted key climate data and reports such as the national climate assessments and the US Global Change Research Program from government websites. The administration has changed 70% more of the information on official environmental websites during its first 100 days than the first Trump administration did, according to a report the research group Environmental Data and Governance Initiative published last week.
In light of these actions, research organizations such as the Public Environmental Data Project and Cornerstone Sustainability Data Initiative have worked to safeguard and publicize data that the federal government is hiding from the public.
'Attacks on science are dangerous because they erode one of society's most effective tools for understanding the world and making decisions in the public interest,' said Dessler. 'When political or ideological forces undermine scientific institutions or discredit experts, they weaken our ability to harness this powerful tool.'
Asked for comment about the NASEM review, an EPA spokesperson repeated a comment offered earlier this month: 'Congress never explicitly gave EPA authority to impose greenhouse gas regulations for cars and trucks.'
The Clean Air Act authorizes the EPA to set emission standards for cars if the EPA administrator determines that their emissions endanger public health or welfare. That includes greenhouse gas emissions, due to the endangerment finding.
Asked for comment on the DOE report supporting the EPA's position, Department of Energy spokesperson Ben Dietderich also repeated an earlier comment. 'This report critically assesses many areas of ongoing scientific inquiry that are frequently assigned high levels of confidence – not by the scientists themselves but by the political bodies involved, such as the United Nations or previous Presidential administrations,' he said.
The UN and the US have regularly convened top scientists to produce scientific climate reports, which warn that urgent action to curb emissions is needed.
Dietderich also said officials 'look forward to engaging with substantive comments' on the report.
However, 'the real question is whether they'll listen to us,' said Dessler.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
3 hours ago
- Daily Mail
The secret to living longer may be the immune system's 'fountain of youth' - but it comes at a price
If you want to reach your 100th birthday and receive a telegram from the King, the answer may be in your immune system. For some over 60s with 'immune youth' have specialised white blood cells that restore strength and muscle mass, scientists have discovered. According to US researchers, who tracked more than 100 older adults, these cells known as Stem-like T cells, give people younger immune systems. But they also discovered those with the cells, also called stem-like memory T cells or TSL, could spread disease more easily. Instead, those with such cells were more likely to have autoimmunity—when the immune system mistakenly attacks healthy tissues and organs instead of defending it. Dr Cornelia Weyand, a rheumatologist, expert in immune cell function at the Mayo Clinic in Minnesota and study co-author, said: 'We observed that these patients have very young immune systems despite being in their 60s and 70s. 'But the price they pay for that is autoimmunity.' Dr Jörg Goronzy, an immunologist at the Mayo Clinic and study co-author, added: 'Contrary to what one may think, there are benefits to having an immune system that ages in tandem with the body. 'We need to consider the price to pay for immune youthfulness. That price can be autoimmune disease.' In the study, researchers tracked the 100 over 60s who attended the Mayo Clinic to receive treatment for giant cell arteritis, an autoimmune disease that affects the arteries, including the aorta. Writing in the journal Nature Aging, they said they found stem-like T cells in the diseased tissue of these patients. They also discovered the immune checkpoint inhibitors that regulate the immune system were not working properly. The scientists said they are now in the process of developing new diagnostic tests that will help find patients and healthy individuals who carry high numbers of immune stem cells and may be predisposed to autoimmune disease later in life. Last year, research suggested life expectancy across the world will rise by almost five years by 2050, with the average man forecasted to live to 76 and woman, past 80. Global average life expectancy is forecast to increase to around 78.1 years of age in 2050, a rise of 4.5 years, The Lancet Public Health study also found. At the time, experts said the trend was largely driven by public health measures both preventing and improving survival rates from illnesses including cardiovascular disease, nutritional diseases and maternal and neonatal infections. Commentators also said the figures present an 'immense opportunity' to 'get ahead of rising metabolic and dietary risk factors' such as high blood pressure and BMI. The oldest living person in the world is now believed to be Ethel Caterham, from Surrey, who was born on August 21, 1909 and is 115 years old. The title of the oldest person to have ever lived belongs to French woman Jeanne Louise Calment whose life spanned 122 years and 164 days. Ms Caterham, who died in 1997, attributed her longevity to 'never arguing with anyone, I listen and I do what I like'. Experts who have studied centenarians agree. Physical activity, faith, love, companionship, and a sense of purpose make up the backbone of so-called 'Blue Zones,' or areas of the world where people typically live to 100 and beyond. Maintaining an active lifestyle, even simply walking around town every day, has been shown to improve longevity. Companionship has been shown to have a similarly positive effect on a person's lifespan, with studies consistently showing loneliness is toxic.


The Sun
3 hours ago
- The Sun
The common deadly fan mistake experts say people do at home that could trigger heart attacks
WITH August's scorching weather showing no signs of letting up, staying cool at home has become more essential than ever. This is why an electric fan is likely to become your new best friend for the coming weeks, while you try to take the edge off and feel cooler. 2 2 But a new study from Australia suggests using the humble device could do more harm than good by increasing your risk of a heart attack. Scientists from the University of Sydney recruited 20 people to test how fans affect body temperature, heart rate, sweating and comfort when used in a hot and humid environment. They also wanted to find out whether hydration levels made any difference, since it's already known that fans can sometimes make heat stress worse. The participants completed the experiment in a climate-controlled chamber set to 39.2C with 49 per cent humidity. In two of the sessions, they were well hydrated, having consumed the recommended amount of fluids for 24 hours beforehand, and were also allowed to drink during the trial. In the other two sessions, they were deliberately dehydrated by avoiding fluids and foods with high water content for 24 hours and were not permitted to drink during the trial. Each hydration state was tested both with and without the use of a fan. A series of temperatures were measured, including their heart rate, rectal temperature, whole body sweat rate, thermal discomfort, and thirst level. The results revealed that fan use while dehydrated can worsen heart strain, which can eventually lead to heart attacks. The experts concluded that using a fan increased sweat losses by about 60 per cent, which could mean using a fan is more harmful if you are dehydrated. How to stay cool during hot weather The study lead, Connor Graham PhD said: "Most extreme heat decedents do not have air conditioning but often own electric fans. "Fan use can reduce heat-related elevations in thermal and cardiovascular strain at temperatures up to approximately 39 to 40C. "In hotter conditions, fans should be turned off, as they can worsen heat stress.' This, Connor said, is because the high temperature of the air causes the body to heat up faster than it can cool itself by sweating. This isn't the first time fans have been linked to an increased risk of heart issues. Previous research has found that fan use can reduce heat and heart strain in temperatures up to around 39C, but once the mercury edges past 40C it's better to turn them off. Researchers have previously also recommended only using fans when it's below 39C for healthy adults below 40 years old and 38C for older adults 65 or older. They also warned fans should only be used in temperatures above 37C in older adults on anticholinergic medications like oxybutynin for bladder control.


Telegraph
4 hours ago
- Telegraph
‘Tailored' prostate cancer treatment can give men extra time
Men with incurable prostate cancer could be given precious extra time by tailored immunotherapy. Scientists have said a new drug combination has had an 'extraordinary' effect on some patients with no other hope, keeping the disease at bay for more than four years. The Neptunes trial found that the drug cocktail could extend life when conventional hormone therapies have stopped working, shrinking tumours when given to the right patients. Hormone-based drugs that block the production of testosterone, slowing or halting the growth of tumours, have become a front-line treatment for many men with metastatic prostate cancer that has spread to other organs. However, the cancer eventually becomes resistant and finds a path to keep spreading. The Telegraph is campaigning for the introduction of targeted prostate cancer screening to boost early diagnosis. A late diagnosis of the disease has been linked to a far worse survival rate. Men diagnosed at an early stage have five-year survival rates of almost 100 per cent, compared to rates of around 50 per cent once it has spread beyond the prostate. Dr Gianmarco Leone, an oncology researcher from the UCL Cancer Institute and the study's lead author, said the trial's findings were particularly promising because the 74 patients enrolled all had advanced cancer and limited options. He said: 'With the standard options, the time that these patients could still benefit from treatment was measured in months, definitely not years. But for a small group of patients, we've seen these extraordinary responses where we were able to achieve long-term benefits.' Previous attempts to use immunotherapy to treat prostate cancer have been largely unsuccessful, with less than 10 per cent of patients responding to the drugs in trials. Compared with other cancers, many prostate tumours are 'immune-cold', which means they either cannot be recognised by the immune system or have a physical or chemical barrier that repels immune cells. But the new research discovered that certain sub-populations of patients with advanced prostate cancer can be exceptions to the rule. The trial by oncologists at University College London Hospitals (UCLH) examined the effect of a combination of immunotherapy drugs – nivolumab and ipilimumab. Some 70 per cent of patients whose tumours have 'mismatch repair deficiency' – which have up to 20 times as many DNA mutations as other tumours – responded to immunotherapy, delaying disease progression by an average of 10 months. In men with prostate cancer caused by the BRCA2 gene, which is better known for its link to breast cancer, 50 per cent responded to the drugs and subsequently went into remission for an average of 17 months. Among men with a high concentration of immune cells around the tumour, 43 per cent had a positive response to the treatment. As a result, a handful of participants were able to fend off the disease's progression for more than four years. Dr Mark Linch, a senior author of the study and consultant oncologist at UCLH, said the results pointed towards more personalised approaches tailored to an individual's tumours being the future of advanced cancer treatment. He said: 'I've been pushing this personalised approach, as unfortunately despite my advice, over the years, the pharmaceutical companies have tended to run very large trials in unselected populations [of prostate cancer patients]. 'And while that's been a winner for lung cancers, melanomas and other tumour types, it's not worked for prostate cancer. So this was our effort to test a new strategy.' Other scientists said they were particularly excited by the response rate in metastatic prostate cancer patients with mismatch repair deficiency. Nick James, a professor of prostate and bladder cancer research at The Institute of Cancer Research, London, said far more men should be tested in case they have mismatch repair deficiency and could benefit from the new treatment. Prof James said: 'This testing is not something that's done very much. So there are probably some patients who might benefit, who we're not testing and therefore never get this treatment.' However, current statistics have shown that mismatch repair deficiency is only present in around 2 per cent of patients, while BRCA gene mutations occur in less than 10 per cent. Although the Neptunes trial included 74 patients, other experts said they were keen to see the approach tested in a larger study of hundreds of patients with such sub-types of advanced prostate cancer. They added that trials could combine it with hormone therapy to see if a dual approach would improve response rates even further. Prof Prasanna Sooriakumaran, a professor of urology at the University of Oxford, said: 'It's really promising because prostate cancer was not previously thought to be very immunogenic.' 'Now we should see whether immunotherapy can have a synergistic effect with the proven treatments which are known to work.'